Method for the immunological determination of an analyte
Abstract
The invention concerns a method for the immunological determination of an analyte in a sample using magnetic particles coated with the analyte to be determined or analyte-specific bonding partners and directly detectable non-magnetic particles coated with analyte-specific bonding partners or the analyte to be determined or using a non-magnetic substance which is indirectly detectable, and incubation of the reaction mixture. The method is characterized in that the magnetic particles are subsequently separated from the reaction mixture using a magnetic test strip and the analyte concentration is determined directly.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A procedure for the immunological determination of an analyte in a sample comprising
a) incubating a sample which may comprise said analyte with
i) magnetic particles coated with a) the analyte to be determined or b) a first analyte-specific binding components and either
ii) directly or indirectly detectable non-magnetic particles coated with a) a second analyte-specific binding component or b) the analyte to be determined, or
iii) an indirectly detectable non-magnetic substance coupled to said second analyte-specific binding component;
b) allowing said analyte and said coated magnetic particles and either said coated non-magnetic particles or said coupled non-magnetic substance to interact;
c) removing said magnetic particles and materials attached thereto by inserting and removing a magnetic test strip; and
d) determining the analyte concentration directly on said removed magnetic test strip.
2. A procedure for the imunological determination of an analyte in a sample comprising
a) incubating a sample which may comprise said analyte with
i) magnetic particles coated with a) the analyte to be determined or b) a first analyte-specific binding components and either
ii) directly or indirectly detectable non-magnetic particles coated with a) a second analyte-specific binding component or b) the analyte to be determined, or
iii) an indirectly detectable non-magnetic substance coupled to said second analyte-specific binding component;
b) allowing said analyte and said coated magnetic particles and either said coated non-magnetic particles or said coupled non-magnetic substance to interact;
c) removing said magnetic particles and materials attached thereto by inserting and removing a magnetic test strip; and
d) determining the analyte concentration indirectly by development of a color reaction or electrochemically on said removed test strip.
3. The method according to claim 1 , wherein said two analyte-specific binding components are antibodies.
4. The method according to claim 3 , wherein said two antibodies are monoclonal antibodies which are specific for different epitopes of said analyte.
5. The method according to claim 1 , wherein said non-magnetic substance is an enzyme.
6. The method according to claim 1 , wherein the magnetic test strip is a flat permanent magnet.
7. The method according to claim 1 , wherein the magnetic test strip can be washed and reused a plurality of times.
8. The method according to claim 1 , wherein said particles have a size of 30 nm to 800 μm.
9. The method according to claim 1 , wherein said particles are of iron, nickel, cobalt, manganese, a lanthanide, a magnetic alloy, an oxide, a composite material, or an organic polymer.
10. The method according to claim 9 , wherein said lanthanide is neodymium or erbium, said magnetic alloy is an aluminum, nickel, cobalt or copper alloy, said oxide is Fe 3 O 4 , CrO 2 , CoO, NiO 2 or Mn 2 O 3 , said composite material is a ferrite, or said organic polymer is a polystyrene.
11. A procedure for the immunological determination of an analyte in a sample, comprising
a) incubating a sample which may comprise said analyte with
(i) magnetic particles coated with a first analyte-specific binding component and
(ii) non-magnetic particles, optionally having a color different from said magnetic particles, coated with a second analyte-specific binding component,
wherein said coated non-magnetic particles are directly or indirectly detectable;
b) allowing said analyte and said coated magnetic particles and said coated non-magnetic particles to interact;
c) removing said magnetic particles and materials attached thereto by inserting and removing a magnetic test strip; and
d) determining the analyte concentration.
12. The method according to claim 11 , wherein said first and second analyte-specific binding components are monoclonal antibodies.
13. A procedure for the immunological determination of an analyte in a sample comprising magnetic particles coated with an analyte-specific component, to which the analyte and directly or indirectly detectable non-magnetic materials are attached, comprising removing said magnetic particles and said directly or indirectly detectable materials attached thereto from said sample by inserting a magnetic test strip into the sample and removing it, and determining the analyte concentration directly on said removed test strip.
14. The method according to claim 13 , wherein said analyte-specific binding component is a monoclonal antibody.
15. A procedure for the immunological determination of an analyte in a sample comprising
a) incubating a sample which may comprise said analyte with
(i) magnetic particles coated with said analyte or with a first analyte-specific component; and
(ii) non-magnetic particles, optionally having a different color from said magnetic particles, coated with a second analyte-specific binding component or with said analyte;
b) allowing said analyte and said coated magnetic particles and said coated non-magnetic particles to interact;
c) removing said magnetic particles and materials attached thereto by inserting and removing a magnetic test strip; and
d) determining the analyte concentration directly on said removed magnetic test strip.
16. The method according to claim 15 , wherein said analyte-specific binding components are monoclonal antibodies.
17. A procedure for the immunological determination of an analyte in a sample, comprising
a) incubating a sample which may comprise said analyte with
(i) magnetic particles coated with a first analyte-specific binding component and
(ii) an indirectly detectable non-magnetic substance, coupled to a second analyte-specific binding component,
b) allowing said analyte and said coated magnetic particle and said non-magnetic substance to interact;
c) removing said magnetic particles and materials attached thereto by inserting and removing a magnetic test strip; and
d) determining the analyte concentration directly on said removed magnetic test strip.
18. The method according to claim 17 , wherein said analyte-specific binding components are monoclonal antibodies.Join the waitlist — get patent alerts
Track US6479302B1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.